{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:12:01Z","timestamp":1764828721113,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010773","name":"Demensf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002960","name":"V\u00e4sterbotten County Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002960","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The aim of this study was to describe changes in the pattern of cardiovascular agents used in elderly people living in nursing homes between 2007 and 2013. Further, the aim was to analyse the use of cardiovascular drugs in relation to cognitive impairment and associated factors within the same population, where prescription of loop diuretics was used as a proxy for heart failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two questionnaire surveys were performed including 2494 people in 2007 and 1654 people in 2013 living in nursing homes in northern Sweden. Data were collected concerning drug use, functioning in activities of daily living (ADL) and cognition, using the Multi-Dimensional Dementia Assessment Scale (MDDAS). The use of different drugs and drug classes among people at four different levels of cognitive function in 2007 and 2013 were compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The proportion of people prescribed ASA and diuretics was significantly lower at all four levels of cognitive function in 2013 compared to 2007. Among people prescribed loop diuretics, the use of angiotensin-converting enzyme inhibitors\/angiotensin II receptor blockers (ACEI\/ARBs) increased from 37.8 to 45.6%, \u03b2-blockers from 36.0 to 41.8% and warfarin from 4.4 to 11.4%. The use of warfarin, ACEI\/ARBs, \u03b2-blockers and mineralocorticoid receptor antagonists (MRAs) were less common among individuals with more severe cognitive impairment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results indicate that cardiovascular drug treatment has improved between 2007 and 2013, but there is room for further improvement, especially regarding adherence to guidelines for heart failure. Increasing cognitive impairment had an effect on treatment patterns for heart failure and atrial fibrillation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00228-019-02778-y","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T06:02:28Z","timestamp":1578463348000},"page":"525-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5229-5988","authenticated-orcid":false,"given":"Sofia","family":"Svahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"L\u00f6vheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Olof","family":"Sandman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"2778_CR1","unstructured":"WHO. World health organization (2017) Cardiovascular diseases (CVDs). Available from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) Accessed 31 March 2019"},{"key":"2778_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/hjh.0000000000001961","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I, List of authors\/Task Force members (2018) Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 36:2284\u20132309. https:\/\/doi.org\/10.1097\/hjh.0000000000001961","journal-title":"J Hypertens"},{"key":"2778_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0140-6736(16)31919-5","volume":"389","author":"B Zhou","year":"2017","unstructured":"Zhou B, Bentham J, Di Cesare M et al (2017) Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 389:37\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(16)31919-5","journal-title":"Lancet"},{"key":"2778_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.amjmed.2007.10.027","volume":"121","author":"DA Duprez","year":"2008","unstructured":"Duprez DA (2008) Systolic hypertension in the elderly: addressing an unmet need. Am J Med 121:179\u2013184.e173. https:\/\/doi.org\/10.1016\/j.amjmed.2007.10.027","journal-title":"Am J Med"},{"key":"2778_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/jhh.2012.14","volume":"27","author":"L Molander","year":"2013","unstructured":"Molander L, Lovheim H (2013) Blood pressure change and antihypertensive treatment in old and very old people: evidence of age, sex and cohort effects. J Hum Hypertens 27:197\u2013203. https:\/\/doi.org\/10.1038\/jhh.2012.14","journal-title":"J Hum Hypertens"},{"key":"2778_CR6","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors\/Task Force Members, Document Reviewers (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891\u2013975. https:\/\/doi.org\/10.1002\/ejhf.592","journal-title":"Eur J Heart Fail"},{"key":"2778_CR7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/s0140-6736(17)31071-1","volume":"390","author":"M Metra","year":"2017","unstructured":"Metra M, Teerlink JR (2017) Heart failure. Lancet 390:1981\u20131995. https:\/\/doi.org\/10.1016\/s0140-6736(17)31071-1","journal-title":"Lancet"},{"key":"2778_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30\u201341. https:\/\/doi.org\/10.1038\/nrcardio.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"2778_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/eurjhf\/hft028","volume":"15","author":"V Lazzarini","year":"2013","unstructured":"Lazzarini V, Mentz RJ, Fiuzat M, Metra M, O'Connor CM (2013) Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail 15:717\u2013723. https:\/\/doi.org\/10.1093\/eurjhf\/hft028","journal-title":"Eur J Heart Fail"},{"key":"2778_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/14656566.2017.1316377","volume":"18","author":"EM Screever","year":"2017","unstructured":"Screever EM, Meijers WC, van Veldhuisen DJ, de Boer RA (2017) New developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations. Expert Opin Pharmacother 18:645\u2013655. https:\/\/doi.org\/10.1080\/14656566.2017.1316377","journal-title":"Expert Opin Pharmacother"},{"key":"2778_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00508-016-1082-x","volume":"128","author":"C Vitale","year":"2016","unstructured":"Vitale C, Rosano G, Fini M (2016) Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment. Wien Klin Wochenschr 128:433\u2013438. https:\/\/doi.org\/10.1007\/s00508-016-1082-x","journal-title":"Wien Klin Wochenschr"},{"key":"2778_CR12","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","volume":"42","author":"JB Braunstein","year":"2003","unstructured":"Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42:1226\u20131233","journal-title":"J Am Coll Cardiol"},{"key":"2778_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.amjmed.2010.08.017","volume":"124","author":"CY Wong","year":"2011","unstructured":"Wong CY, Chaudhry SI, Desai MM, Krumholz HM (2011) Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med 124:136\u2013143. https:\/\/doi.org\/10.1016\/j.amjmed.2010.08.017","journal-title":"Am J Med"},{"key":"2778_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s00508-016-1138-y","volume":"128","author":"N Cvetinovic","year":"2016","unstructured":"Cvetinovic N, Loncar G, Farkas J (2016) Heart failure management in the elderly - a public health challenge. Wien Klin Wochenschr 128:466\u2013473. https:\/\/doi.org\/10.1007\/s00508-016-1138-y","journal-title":"Wien Klin Wochenschr"},{"key":"2778_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","volume":"11","author":"F Rahman","year":"2014","unstructured":"Rahman F, Kwan GF, Benjamin EJ (2014) Global epidemiology of atrial fibrillation. Nat Rev Cardiol 11:639\u2013654. https:\/\/doi.org\/10.1038\/nrcardio.2014.118","journal-title":"Nat Rev Cardiol"},{"key":"2778_CR16","doi-asserted-by":"publisher","first-page":"e1732","DOI":"10.1212\/wnl.0000000000006456","volume":"91","author":"M Ding","year":"2018","unstructured":"Ding M, Fratiglioni L, Johnell K, Santoni G, Fastbom J, Ljungman P, Marengoni A, Qiu C (2018) Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study. Neurology 91:e1732\u2013e1740. https:\/\/doi.org\/10.1212\/wnl.0000000000006456","journal-title":"Neurology"},{"key":"2778_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63\u201375.e62. https:\/\/doi.org\/10.1016\/j.jalz.2012.11.007","journal-title":"Alzheimers Dement"},{"key":"2778_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1017\/S1041610297003943","volume":"8","author":"SI Finkel","year":"1996","unstructured":"Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N (1996) Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 8:497\u2013500","journal-title":"Int Psychogeriatr"},{"key":"2778_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00228-015-1825-z","volume":"71","author":"M Gustafsson","year":"2015","unstructured":"Gustafsson M, Sandman P-O, Karlsson S, Isaksson U, Schneede J, Sj\u00f6lander M, L\u00f6vheim H (2015) Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013. Eur J Clin Pharmacol 71:507\u2013515. https:\/\/doi.org\/10.1007\/s00228-015-1825-z","journal-title":"Eur J Clin Pharmacol"},{"key":"2778_CR20","first-page":"209","volume":"2","author":"GA Heckman","year":"2007","unstructured":"Heckman GA, Patterson CJ, Demers C, St Onge J, Turpie ID, McKelvie RS (2007) Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging 2:209\u2013218","journal-title":"Clin Interv Aging"},{"key":"2778_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1532-5415.2005.00543.x","volume":"54","author":"CC Schubert","year":"2006","unstructured":"Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, Unverzagt F, Hui S, Hendrie HC (2006) Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc 54:104\u2013109. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.00543.x","journal-title":"J Am Geriatr Soc"},{"key":"2778_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1532-5415.2004.52054.x","volume":"52","author":"JP Bynum","year":"2004","unstructured":"Bynum JP, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW (2004) The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc 52:187\u2013194","journal-title":"J Am Geriatr Soc"},{"key":"2778_CR23","first-page":"e488","volume":"64","author":"N Drummond","year":"2018","unstructured":"Drummond N, McCleary L, Freiheit E, Molnar F, Dalziel W, Cohen C, Turner D, Miyagishima R, Silvius J (2018) Antidepressant and antipsychotic prescribing in primary care for people with dementia. Can Fam Physician 64:e488\u2013e497","journal-title":"Can Fam Physician"},{"key":"2778_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/jad-170265","volume":"60","author":"AJ Cross","year":"2017","unstructured":"Cross AJ, George J, Woodward MC, Ames D, Brodaty H, Wolfe R, Connors MH, Elliott RA (2017) Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics. J Alzheimers Dis 60:349\u2013358. https:\/\/doi.org\/10.3233\/jad-170265","journal-title":"J Alzheimers Dis"},{"key":"2778_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00228-017-2218-2","volume":"73","author":"E Sonnerstam","year":"2017","unstructured":"Sonnerstam E, Sjolander M, Gustafsson M (2017) An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list. Eur J Clin Pharmacol 73:735\u2013742. https:\/\/doi.org\/10.1007\/s00228-017-2218-2","journal-title":"Eur J Clin Pharmacol"},{"key":"2778_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000093739","volume":"22","author":"M Lopponen","year":"2006","unstructured":"Lopponen M, Raiha I, Isoaho R, Vahlberg T, Puolijoki H, Kivela SL (2006) Dementia associates with undermedication of cardiovascular diseases in the elderly: a population-based study. Dement Geriatr Cogn Disord 22:132\u2013141. https:\/\/doi.org\/10.1159\/000093739","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2778_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/pds.878","volume":"12","author":"I Klarin","year":"2003","unstructured":"Klarin I, Fastbom J, Wimo A (2003) A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort. Pharmacoepidemiol Drug Saf 12:669\u2013678. https:\/\/doi.org\/10.1002\/pds.878","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2778_CR28","first-page":"120","volume":"2","author":"PO Sandman","year":"1988","unstructured":"Sandman PO, Adolfsson R, Norberg A, Nystrom L, Winblad B (1988) Long-term care of the elderly. A descriptive study of 3600 institutionalized patients in the county of Vasterbotten, Sweden. Compr Gerontol A 2:120\u2013132","journal-title":"Compr Gerontol A"},{"key":"2778_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1600-0447.1981.tb00670.x","volume":"63","author":"R Adolfsson","year":"1981","unstructured":"Adolfsson R, Gottfries CG, Nystrom L, Winblad B (1981) Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand 63:225\u2013244","journal-title":"Acta Psychiatr Scand"},{"key":"2778_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00228-016-2058-5","volume":"72","author":"M Gustafsson","year":"2016","unstructured":"Gustafsson M, Isaksson U, Karlsson S, Sandman PO, Lovheim H (2016) Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013. Eur J Clin Pharmacol 72:987\u2013994. https:\/\/doi.org\/10.1007\/s00228-016-2058-5","journal-title":"Eur J Clin Pharmacol"},{"key":"2778_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"2778_CR32","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1017\/s104161021000061x","volume":"22","author":"H Lovheim","year":"2010","unstructured":"Lovheim H, Bergdahl E, Sandman PO, Karlsson S, Gustafson Y (2010) One-week prevalence of depressive symptoms and psychotropic drug treatments among old people with different levels of cognitive impairment living in institutional care: changes between 1982 and 2000. Int Psychogeriatr 22:1154\u20131160. https:\/\/doi.org\/10.1017\/s104161021000061x","journal-title":"Int Psychogeriatr"},{"key":"2778_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/s1041610217001703","volume":"30","author":"A Skottheim","year":"2018","unstructured":"Skottheim A, Lovheim H, Isaksson U, Sandman PO, Gustafsson M (2018) Insomnia symptoms among old people in nursing homes. Int Psychogeriatr 30:77\u201385. https:\/\/doi.org\/10.1017\/s1041610217001703","journal-title":"Int Psychogeriatr"},{"key":"2778_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104519","volume":"9","author":"N McCormick","year":"2014","unstructured":"McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA (2014) Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLoS One 9:e104519. https:\/\/doi.org\/10.1371\/journal.pone.0104519","journal-title":"PLoS One"},{"issue":"2","key":"2778_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.15420\/cfr.2015.1.2.90","volume":"1","author":"P Pellicori","year":"2015","unstructured":"Pellicori P, Kaur K, Clark AL (2015) Fluid management in patients with chronic heart failure. Card Fail Rev 1(2):90\u201395. https:\/\/doi.org\/10.15420\/cfr.2015.1.2.90","journal-title":"Card Fail Rev"},{"key":"2778_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/jhh.2013.107","volume":"28","author":"LC Beishon","year":"2014","unstructured":"Beishon LC, Harrison JK, Harwood RH, Robinson TG, Gladman JR, Conroy SP (2014) The evidence for treating hypertension in older people with dementia: a systematic review. J Hum Hypertens 28:283\u2013287. https:\/\/doi.org\/10.1038\/jhh.2013.107","journal-title":"J Hum Hypertens"},{"key":"2778_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/bf03319101","volume":"35","author":"F Salvi","year":"2012","unstructured":"Salvi F, Marchetti A, D'Angelo F, Boemi M, Lattanzio F, Cherubini A (2012) Adverse drug events as a cause of hospitalization in older adults. Drug Saf 35:29\u201345. https:\/\/doi.org\/10.1007\/bf03319101","journal-title":"Drug Saf"},{"key":"2778_CR38","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jamda.2014.03.005","volume":"15","author":"V van der Wardt","year":"2014","unstructured":"van der Wardt V, Logan P, Conroy S, Harwood R, Gladman J (2014) Antihypertensive treatment in people with dementia. J Am Med Dir Assoc 15:620\u2013629. https:\/\/doi.org\/10.1016\/j.jamda.2014.03.005","journal-title":"J Am Med Dir Assoc"},{"key":"2778_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00041552-200403000-00011","volume":"13","author":"WH Birkenhager","year":"2004","unstructured":"Birkenhager WH, Forette F, Staessen JA (2004) Dementia and antihypertensive treatment. Curr Opin Nephrol Hypertens 13:225\u2013230","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2778_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneur.60.2.223","volume":"60","author":"C Qiu","year":"2003","unstructured":"Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L (2003) Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol 60:223\u2013228","journal-title":"Arch Neurol"},{"key":"2778_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3233\/jad-2010-100288","volume":"21","author":"AH van Beek","year":"2010","unstructured":"van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA (2010) Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use. J Alzheimers Dis 21:519\u2013526. https:\/\/doi.org\/10.3233\/jad-2010-100288","journal-title":"J Alzheimers Dis"},{"key":"2778_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","volume":"29","author":"L Rouch","year":"2015","unstructured":"Rouch L, Cestac P, Hanon O, Cool C, Helmer C, Bouhanick B, Chamontin B, Dartigues JF, Vellas B, Andrieu S (2015) Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 29:113\u2013130. https:\/\/doi.org\/10.1007\/s40263-015-0230-6","journal-title":"CNS Drugs"},{"key":"2778_CR43","unstructured":"Swedish Medical Products Agency (2006) Hj\u00e4rtsvikt. [Eng Heart failure] Available from https:\/\/lakemedelsverketse\/malgrupp\/Halso%2D%2D-sjukvard\/Behandlings%2D%2Drekommendationer\/Behandlingsrekommendation%2D%2D-listan\/Hjartsvikt\/ Accessed 31 March 2019"},{"key":"2778_CR44","unstructured":"The National Board of Health and Welfare (2008) Hj\u00e4rtsvikt - Vetenskapligt underlag f\u00f6r Nationella riktlinjer f\u00f6r hj\u00e4rtsjukv\u00e5rd 2008. [Eng. Heart failure - Scientific grounds for National guidelines for Cardiac Care 2008]"},{"key":"2778_CR45","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, K\u00f8ber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, R\u00f8nnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, ESC Committee for Practice Guidelines (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803\u2013869. https:\/\/doi.org\/10.1093\/eurjhf\/hfs105","journal-title":"Eur J Heart Fail"},{"key":"2778_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1874192401105010130","volume":"5","author":"GM Currie","year":"2011","unstructured":"Currie GM, Wheat JM, Kiat H (2011) Pharmacokinetic considerations for digoxin in older people. Open Cardiovasc Med J 5:130\u2013135. https:\/\/doi.org\/10.2174\/1874192401105010130","journal-title":"Open Cardiovasc Med J"},{"key":"2778_CR47","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","volume":"59","author":"S Ather","year":"2012","unstructured":"Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59:998\u20131005. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.040","journal-title":"J Am Coll Cardiol"},{"key":"2778_CR48","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2013) ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147\u2013e239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"key":"2778_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjopharm.2011.11.003","volume":"10","author":"GB Rattinger","year":"2012","unstructured":"Rattinger GB, Dutcher SK, Chhabra PT, Franey CS, Simoni-Wastila L, Gottlieb SS, Stuart B, Zuckerman IH (2012) The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure. Am J Geriatr Pharmacother 10:69\u201380. https:\/\/doi.org\/10.1016\/j.amjopharm.2011.11.003","journal-title":"Am J Geriatr Pharmacother"},{"key":"2778_CR50","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1161\/circulationaha.106.177292","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryden LE, Cannom DS et al (2006) ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257\u2013e354. https:\/\/doi.org\/10.1161\/circulationaha.106.177292","journal-title":"Circulation"},{"issue":"21","key":"2778_CR51","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719\u20132747. https:\/\/doi.org\/10.1093\/eurheartj\/ehs253","journal-title":"Eur Heart J"},{"key":"2778_CR52","unstructured":"The National Board of Health and Welfare (2008) Nationella riktlinjer f\u00f6r hj\u00e4rtsjukv\u00e5rd 2008 - beslutsst\u00f6d f\u00f6r prioriteringar. [Eng. National guidelines for Cardiac Care 2008 - decision support for priorities]"},{"key":"2778_CR53","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/europace\/euq350","volume":"12","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, van Gelder I, al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, de Caterina R, de Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, le Heuzey JY, Ponikowski P, Rutten FH, ESC Committee for Practice Guidelines (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360\u20131420. https:\/\/doi.org\/10.1093\/europace\/euq350","journal-title":"Europace"},{"key":"2778_CR54","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/strokeaha.117.016902","volume":"48","author":"P Appelros","year":"2017","unstructured":"Appelros P, Farahmand B, Terent A, Asberg S (2017) To treat or not to treat: anticoagulants as secondary preventives to the oldest old with atrial fibrillation. Stroke 48:1617\u20131623. https:\/\/doi.org\/10.1161\/strokeaha.117.016902","journal-title":"Stroke"},{"key":"2778_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/14740338.2012.712109","volume":"11","author":"F Deepinder","year":"2012","unstructured":"Deepinder F, Braunstein GD (2012) Drug-induced gynecomastia: an evidence-based review. Expert Opin Drug Saf 11:779\u2013795. https:\/\/doi.org\/10.1517\/14740338.2012.712109","journal-title":"Expert Opin Drug Saf"},{"key":"2778_CR56","doi-asserted-by":"publisher","first-page":"e0155228","DOI":"10.1371\/journal.pone.0155228","volume":"11","author":"H Zhang","year":"2016","unstructured":"Zhang H, Plutzky J, Shubina M, Turchin A (2016) Drivers of the sex disparity in statin therapy in patients with coronary artery disease: a cohort study. PLoS One 11:e0155228. https:\/\/doi.org\/10.1371\/journal.pone.0155228","journal-title":"PLoS One"},{"key":"2778_CR57","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.amjcard.2014.02.018","volume":"113","author":"BM Victor","year":"2014","unstructured":"Victor BM, Teal V, Ahedor L, Karalis DG (2014) Gender differences in achieving optimal lipid goals in patients with coronary artery disease. Am J Cardiol 113:1611\u20131615. https:\/\/doi.org\/10.1016\/j.amjcard.2014.02.018","journal-title":"Am J Cardiol"},{"key":"2778_CR58","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.jacl.2016.09.010","volume":"10","author":"H Zhang","year":"2016","unstructured":"Zhang H, Plutzky J, Shubina M, Turchin A (2016) Risk factors for lack of statin therapy in patients with diabetes and coronary artery disease. J Clin Lipidol 10:1406\u20131413. https:\/\/doi.org\/10.1016\/j.jacl.2016.09.010","journal-title":"J Clin Lipidol"},{"key":"2778_CR59","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1046\/j.1532-5415.2002.50515.x","volume":"50","author":"EG Rodriguez","year":"2002","unstructured":"Rodriguez EG, Dodge HH, Birzescu MA, Stoehr GP, Ganguli M (2002) Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study. J Am Geriatr Soc 50:1852\u20131856","journal-title":"J Am Geriatr Soc"},{"key":"2778_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00228-018-2574-6","volume":"75","author":"P Paren","year":"2019","unstructured":"Paren P, Rosengren A, Zverkova Sandstrom T, Schaufelberger M (2019) Decrease in loop diuretic treatment from 2005 to 2014 in Swedish real-life patients with chronic heart failure. Eur J Clin Pharmacol 75:247\u2013254. https:\/\/doi.org\/10.1007\/s00228-018-2574-6","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02778-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:15:29Z","timestamp":1609978529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02778-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2778"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02778-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2020,1,8]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}